No Detail Found!

Evaluation of acute and chronic hepatotoxic effect of CMF in breast cancer patients.

Author(s)
M. Obaid-Ur-Rahman Abbasi Shaheed Hospital/Karachi Medical & Dental College, Karachi, Pakistan
Shazia Qasim Bagai Medical University, Karachi, Pakistan
M. Tariq Aftab Department of Pharmacology and Therapeutics, Karachi Medical and Dental College, Karachi/ Cancer Unit, Abbasi Shaheed Hospital, Karachi, Pakistan
Abstract
CMF regimen contains Cyclophosphamide, Methotrexate and 5 fluorouracil which was developed in "Istituto Nazionale Tumori in Milan and has found to be effective in both pre-menopausal and and post­menopausal breast cancer patients. Since it contains some hepatotoxic drug components so we tried to evaluate the cumulative hepatotoxicity of this combination, both in acute and chronic phases. In case of acute toxicity the regimen is found to be safe. However in case of chronic toxicity, it is found to produce mild effects in patients receiving less than three cycles and moderate effects in patients receiving more than three cycles. This represents that benefit versus risk should be assessed before giving CMF regimen to the patients, especially when other drugs like analgesics or antidepressants are prescribed with it.
Publication Details
Page(s) 41-45
DOI DOI not available
Published Journal: Pakistan Journal of Pharmacy, Volume: 21, Issue: 1, Year: 2004

Request the full text from PASTIC

0

Citations

0

Downloads

56

Views